{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:20:45Z","timestamp":1755926445020,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00640","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:03:12Z","timestamp":1588914192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential"],"prefix":"10.3389","volume":"10","author":[{"given":"Jacob E.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Greiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa C.","family":"Bouska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javeed","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E.","family":"Cutucache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3109\/10428194.2012.743655","article-title":"Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States","volume":"54","author":"Liu","year":"2013","journal-title":"Leuk Lymphoma."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"B4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bjhh.2016.09.014","article-title":"Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges","volume":"39","author":"Santos","year":"2017","journal-title":"Rev Bras Hematol Hemoter."},{"key":"B5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/MOH.0b013e3283477815","article-title":"Non-MALT marginal zone lymphoma","volume":"18","author":"Thieblemont","year":"2011","journal-title":"Curr Opin Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chac\u00f3n","year":"2002","journal-title":"Blood."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1586\/era.09.91","article-title":"Clinical and biological diversity of splenic marginal zone lymphoma","volume":"9","author":"Matutes","year":"2009","journal-title":"Expert Rev Anticancer Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas\u2020","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","article-title":"Splenic marginal zone lymphoma: from genetics to management","volume":"127","author":"Arcaini","year":"2016","journal-title":"Blood."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3332\/ecancer.2018.887","article-title":"Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma","volume":"12","author":"Oliveira","year":"2018","journal-title":"Ecancermedicalscience."},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ctrv.2016.11.016","article-title":"Splenic irradiation for splenomegaly: a systematic review","volume":"53","author":"Zaorsky","year":"2017","journal-title":"Cancer Treat Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation","volume":"28","author":"Mart\u00ednez","year":"2014","journal-title":"Leukemia."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2015","journal-title":"Leukemia."},{"key":"B20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1182\/asheducation-2017.1.371","article-title":"Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma","volume":"2017","author":"Thieblemont","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B21","doi-asserted-by":"publisher","first-page":"30005","DOI":"10.18632\/oncotarget.25487","article-title":"Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA","volume":"9","author":"Robinson","year":"2018","journal-title":"Oncotarget."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fern\u00e0ndez","year":"2010","journal-title":"Cancer Res."},{"key":"B24","first-page":"2109","article-title":"Gene expression profiling of gastric cancer","volume":"18","author":"Jiang","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1471-2164-7-278","article-title":"Converting a breast cancer microarray signature into a high-throughput diagnostic test","volume":"7","author":"Glas","year":"2006","journal-title":"BMC Genomics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1182\/blood-2006-09-046391","article-title":"Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling","volume":"109","author":"Sakhinia","year":"2007","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.amjmed.2008.02.014","article-title":"Complications of splenectomy","volume":"121","author":"Cadili","year":"2008","journal-title":"Am J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3324\/haematol.2013.092460","article-title":"Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up","volume":"99","author":"Kristinsson","year":"2014","journal-title":"Haematologica."},{"key":"B29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijsu.2013.11.017","article-title":"Benefits and risks of splenectomy","volume":"12","author":"Weledji","year":"2014","journal-title":"Int J Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0032-1330064","article-title":"Image-guided percutaneous splenic biopsy and drainage","volume":"29","author":"Sammon","year":"2012","journal-title":"Semin Intervent Radiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0142682","DOI":"10.1371\/journal.pone.0142682","article-title":"Conserved molecular underpinnings and characterization of a role for caveolin-1 in the tumor microenvironment of mature T-cell lymphomas","volume":"10","author":"Herek","year":"2015","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2172-5-20","article-title":"Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs","volume":"5","author":"Shen","year":"2004","journal-title":"BMC Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics."},{"key":"B35","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","article-title":"An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma","volume":"7","author":"Watkins","year":"2012","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/1120009X.2015.1114222","article-title":"How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases","volume":"29","author":"Cervetti","year":"2017","journal-title":"J Chemother."},{"key":"B39","first-page":"13","article-title":"Insights into lymphoma from the 2018 American Society of Clinical Oncology annual meeting: commentary","volume":"16","author":"Andorsky","year":"2018","journal-title":"Clin Adv Hematol Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/bjh.15454","article-title":"High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO","volume":"182","author":"Avivi","year":"2018","journal-title":"Br J Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11912-018-0687-9","article-title":"Marginal zone lymphoma: clinicopathologic variations and approaches to therapy","volume":"20","author":"Ayyappan","year":"2018","journal-title":"Curr Oncol Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.celrep.2014.04.007","article-title":"MUS81-EME2 promotes replication fork restart","volume":"7","author":"Pepe","year":"2014","journal-title":"Cell Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1182\/blood-2014-10-605584","article-title":"Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies","volume":"125","author":"Peterson","year":"2015","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1038\/s41467-018-06178-1","article-title":"USP24 induces IL-6 in tumor-associated microenvironment by stabilizing p300 and \u03b2-TrCP and promotes cancer malignancy","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4049\/jimmunol.1600882","article-title":"ZBTB32 restricts the duration of memory B cell recall responses","volume":"197","author":"Jash","year":"2016","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1200\/JCO.2007.13.5806","article-title":"ERCC5 is a novel biomarker of ovarian cancer prognosis","volume":"26","author":"Walsh","year":"2008","journal-title":"J Clin Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.7150\/jca.25356","article-title":"Polymorphisms in ERCC2 and ERCC5 and risk of prostate cancer: a meta-analysis and systematic review","volume":"9","author":"Liu","year":"2018","journal-title":"J Cancer."},{"key":"B48","first-page":"199","article-title":"Expression of XPG protein in human normal and tumor tissues","volume":"6","author":"Aracil","year":"2013","journal-title":"Int J Clin Exp Pathol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ng.2696","article-title":"Somatic SETBP1 mutations in myeloid malignancies","volume":"45","author":"Makishima","year":"2013","journal-title":"Nat Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2009-06-227363","article-title":"SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia","volume":"115","author":"Cristobal","year":"2010","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"86300","DOI":"10.18632\/oncotarget.13383","article-title":"Myb expression is critical for myeloid leukemia development induced by Setbp1 activation","volume":"7","author":"Nguyen","year":"2016","journal-title":"Oncotarget."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.mpdhp.2009.12.007","article-title":"Lymphomas involving the spleen","volume":"16","author":"Wilkins","year":"2010","journal-title":"Diagn Histopathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"385","DOI":"10.12998\/wjcc.v4.i12.385","article-title":"Primary splenic lymphoma: current diagnostic trends","volume":"4","author":"Ingle","year":"2016","journal-title":"World J Clin Cases."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:03:17Z","timestamp":1588914197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":54,"alternative-id":["10.3389\/fonc.2020.00640"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00640","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"640"}}